DisforDiabetes.com

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com is a press release: Preventive treatment reduces diabetic retinopathy complications

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com is a “Dear Doctor” letter: Updates to Medtronic Product Portfolio

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com is a press release: NIH funds first nationwide network to study rare forms of diabetes

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com  is a commentary: People with Diabetes Should Get Flu Shots

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com is from the USEEOC: Diabetes in the Workplace and the ADA

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com is a press release: Medtronic and Tandem Diabetes Care Enter Into Patent Cross-License Agreement

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com is a press release: Abbott and Tandem Diabetes Care Advance Development of Integrated Technologies for Future Automated Insulin Delivery Systems

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com is a press release from the NIH: New study links severe sleep apnea to higher blood glucose levels in African Americans

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpqage at DisforDiabetes.com is a press release from the FDA:

FDA Proposes Broad Approach for Conducting Safety Trials for Type 2 Diabetes Medications

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com is a press release from the FDA: FDA Proposes Broad Approach for Conducting Safety Trials for Type 2 Diabetes Medications

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com is a press release: AADE rebrands as Association of Diabetes Care & Education Specialists

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com is a press release from the FDA:  FDA authorizes first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com             is a press release: Statement from Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research, on impurities found in diabetes drugs outside the U.S.

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com is a press release: Artificial pancreas system better controls blood glucose levels than current technology

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com is a press release: FDA approves first oral GLP-1 treatment for type 2 diabetes

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com is a press release from the FDA: FDA approves new treatment for pediatric patients with type 2 diabetes

[drbillquick]

The newest webpage at DisforDiabetes.com

The newest webpage at DisforDiabetes.com is a press release from the NIH:    Researchers get a handle on how to control blood sugar after stroke